Profiel
Daniel Schwartzlose is currently Managing Director at NC Advisory A since 2022.
Mr. Schwartzlose was President & Xellia International at Xellia Pharmaceuticals AS from 2019 to 2022 and worked at Xellia Pharmaceuticals AS from 2014 to 2022.
Mr. Schwartzlose earned an MBA from the University of Technology Sydney in 2002 and graduated from the University of Copenhagen in 2003.
Actieve functies van Daniel Schwartzlose
| Bedrijven | Functie | Begin |
|---|---|---|
NC Advisory A/S
NC Advisory A/S Investment ManagersFinance Functions as an alternative investment manager | Private Equity Investor | 01-01-2022 |
Eerdere bekende functies van Daniel Schwartzlose
| Bedrijven | Functie | Einde |
|---|---|---|
Xellia Pharmaceuticals AS
Xellia Pharmaceuticals AS Pharmaceuticals: MajorHealth Technology Develops, manufactures and supplies pharmaceutical drugs | Private Equity Investor | 01-01-2022 |
Opleiding van Daniel Schwartzlose
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
University of Technology Sydney
University of Technology Sydney Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Copenhagen
University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Xellia Pharmaceuticals AS
Xellia Pharmaceuticals AS Pharmaceuticals: MajorHealth Technology Develops, manufactures and supplies pharmaceutical drugs | Health Technology |
NC Advisory A/S
NC Advisory A/S Investment ManagersFinance Functions as an alternative investment manager | Finance |
















